VEXAS SYNDROME
Clinical trials for VEXAS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new VEXAS SYNDROME trials appear
Sign up with your email to follow new studies for VEXAS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare inflammatory disease: pacritinib trial begins
Disease control Recruiting nowThis study tests a drug called pacritinib for people with VEXAS syndrome, a rare genetic condition that causes severe inflammation. About 78 adults will receive either one of two doses of pacritinib or a placebo to see if it helps control symptoms. The goal is to find the best do…
Matched conditions: VEXAS SYNDROME
Phase: PHASE2 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
New registry aims to unlock secrets of rare VEXAS syndrome
Knowledge-focused Recruiting nowThis study will gather real-world information from 500 adults with VEXAS syndrome across Germany. Researchers will track symptoms, treatments, and disease patterns, and collect blood or tissue samples to study genetic links and find better ways to diagnose and monitor the conditi…
Matched conditions: VEXAS SYNDROME
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated May 17, 2026 02:39 UTC